These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 30650407)
41. Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment. Katyal J; Kumar H; Gupta YK Epilepsy Behav; 2015 Mar; 44():98-103. PubMed ID: 25660085 [TBL] [Abstract][Full Text] [Related]
42. Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis. Schwartz JI; Agrawal NG; Wong PH; Miller J; Bachmann K; Marbury T; Hoelscher D; Cavanaugh PF; Gottesdiener K J Clin Pharmacol; 2009 Oct; 49(10):1202-9. PubMed ID: 19783714 [TBL] [Abstract][Full Text] [Related]
43. Thalidomide-associated thrombocytopenia. Duyvendak M; Naunton M; Kingma BJ; Brouwers JR Ann Pharmacother; 2005 Nov; 39(11):1936-9. PubMed ID: 16219892 [TBL] [Abstract][Full Text] [Related]
52. Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen. De Vecchis R; Baldi C; Di Biase G; Ariano C; Cioppa C; Giasi A; Valente L; Cantatrione S Minerva Cardioangiol; 2014 Dec; 62(6):437-48. PubMed ID: 25029569 [TBL] [Abstract][Full Text] [Related]
53. Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol. Moraes BM; do Amaral BC; Morimoto MS; Vieira LG; Perazzo FF; Carvalho JC Inflammopharmacology; 2007 Aug; 15(4):175-8. PubMed ID: 17701021 [TBL] [Abstract][Full Text] [Related]
54. [Severe thrombocytopenia induced by radiographic non-ionic contrast medium]. Saitoh T; Saiki M; Sawada U; Kawamura N; Tohno H; Horie T Rinsho Ketsueki; 2001 Jun; 42(6):507-11. PubMed ID: 11505531 [TBL] [Abstract][Full Text] [Related]
55. A case report on toxic epidermal necrolysis with etoricoxib. Kameshwari JS; Devde R Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388 [TBL] [Abstract][Full Text] [Related]
56. Cardiovascular and hematologic effects produced by chronic treatment with etoricoxib in normotensive rats. Baracho NC; Guizelli GP; Carmello BL; Sanches Dde S; Silva FM; Reis JM; Brito Jd Acta Cir Bras; 2009; 24(3):206-10. PubMed ID: 19504003 [TBL] [Abstract][Full Text] [Related]
57. [Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent thrombosis following thrombocytopenia remission--a case report]. Elikowski W; Rzeźniczak J; Słomczyński M; Psuja P Kardiol Pol; 2005 Jan; 62(1):44-7; discussion 48. PubMed ID: 15815778 [TBL] [Abstract][Full Text] [Related]
58. [Acute profound thrombocytopenia associated with tirofiban: clinical approach to diagnosis and therapeutic management]. Agnelli D; Ottani F G Ital Cardiol (Rome); 2008 Feb; 9(2):137-43. PubMed ID: 18383777 [TBL] [Abstract][Full Text] [Related]
59. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Laine L; Curtis SP; Cryer B; Kaur A; Cannon CP; Lancet; 2007 Feb; 369(9560):465-73. PubMed ID: 17292766 [TBL] [Abstract][Full Text] [Related]
60. Possible case of levofloxacin-induced thrombocytopenia. Salloum R; Liu CY; Weise AM Am J Health Syst Pharm; 2011 Jan; 68(1):43-6. PubMed ID: 21164064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]